1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > IMS Country Review 2016: UK

IMS Country Review 2016: UK

  • July 2016
  • -
  • IMS Health
  • -
  • 81 pages

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Table Of Contents

IMS Country Review 2016: UK
Table of Contents
SECTION 1: SYNOPSIS OF THE HEALTHCARE MARKET 5
MARKET TRENDS 5
HEALTHCARE PROVISION 5
PRESCRIBING POLICY 5
PRICING SYSTEM 5
REGULATORY ENVIRONMENT 5
INDUSTRY ENVIRONMENT 5
CHANNELS OF DISTRIBUTION 10
UNITED KINGDOM DATA COLLECTION 11
SECTION 2: COUNTRY SALES PERFORMANCE AND TRENDS 12
FIGURE 1: COUNTRY RANKING AMONGST 30 MARKETS WORLDWIDE 12
FIGURE 2: AUDITED MARKET TREND 13
FIGURE 3: LEADING 35 LOCAL COMPANIES 14
FIGURE 4: LEADING 35 CORPORATIONS 16
FIGURE 5: MARKET SHARE BY CORPORATE NATIONALITY 18
FIGURE 6: LEADING 15 THERAPEUTIC CLASSES (LEVEL 3) 2015 19
FIGURE 7: 15 FASTEST-GROWING THERAPEUTIC CLASSES (LEVEL 3) 2015 20
FIGURE 8-22: LEADING 15 THERAPEUTIC CLASS PROFILES 21
FIGURE 8: A10P SGLT2 INHIBITOR A-DIABS 21
FIGURE 9: B1F DIRECT FACTOR XA INHIBS 22
FIGURE 10: C10A CHOLESTandTRIGLY.REGULATOR 23
FIGURE 11: J1E TRIMETHOPRIM COMBS 24
FIGURE 12: J5B ANTIVIRALS EXCL ANTI-HIV 25
FIGURE 13: J5C HIV ANTIVIRALS 26
FIGURE 14: L1G MAB ANTINEOPLASTICS 27
FIGURE 15: L1H PROTEIN KINASE INH A-NEO 28
FIGURE 16: L4B ANTI-TNF PRODUCTS 29
FIGURE 17: L4X OTHER IMMUNOSUPPRESSANTS 30
FIGURE 18: N3A ANTI-EPILEPTICS 31
FIGURE 19: N6A ANTIDEPRESS.and MOOD STAB. 32
FIGURE 20: N7X ALL OTHER CNS DRUGS 33
FIGURE 21: R3F B2-STIMULANTS+CORTICOIDS 34
FIGURE 22: S1P OCULAR ANTINEOVASC.PRODS 35
FIGURE 23: LEADING 40 PRODUCTS 36
FIGURE 24: LEADING 40 NEW PRODUCTS 38
FIGURE 25: LEADING 15 PRODUCT FORMS 41
FIGURE 26: FASTEST GROWING 40 PRODUCTS SALES TRENDS 42
SECTION 3: APPENDICES 44
APPENDIX 1: AUDITED UNIVERSE 44
APPENDIX 2: COUNTRY SPECIFIC ALERTS 45
APPENDIX 3: MEASURE INDEX 48
APPENDIX 4: SALES DATA MEASURES 50
APPENDIX 5: *LATEST FACTORS 52
APPENDIX 6: QUARTERLY US$ EXCHANGE RATES BY COUNTRY 56
APPENDIX 7: CORPORATIONS 58
APPENDIX 8: PRODUCT NAMES 59
APPENDIX 9: THERAPIES 61
APPENDIX 10: EPHMRA ANATOMICAL THERAPEUTIC CLASSIFICATION 62

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 US Clinical Chemistry and Immunodiagnostics Market: Hospitals, Commercial Laboratories, POC Locations

2017 US Clinical Chemistry and Immunodiagnostics Market: Hospitals, Commercial Laboratories, POC Locations

  • $ 7500
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the US ...

Hospital Acquired Infection Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hospital Acquired Infection Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Hospital Acquired Infection Treatment Market: Overview This report on hospital acquired infection treatment, studies the current as well as future prospects of the market globally. Hospital infections ...

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017

  • $ 2995
  • Industry report
  • February 2017
  • by Currentpartnering

Summary The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the co-development deals ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.